Beam Therapeutics Inc (BEAM)vsRevolution Medicines Inc (RVMD)
BEAM
Beam Therapeutics Inc
$29.40
-10.48%
HEALTHCARE · Cap: $2.99B
RVMD
Revolution Medicines Inc
$155.69
+4.02%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Beam Therapeutics Inc generates 22004% more annual revenue ($164.01M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -40.2%. BEAM earns a higher WallStSmart Score of 35/100 (F).
BEAM
Avoid35
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 324.9% year-over-year
Conservative balance sheet, low leverage
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
ROE of -5.8% — below average capital efficiency
Negative free cash flow — burning cash
Currently unprofitable
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BEAM
The strongest argument for BEAM centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 324.9% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : BEAM
The primary concerns for BEAM are EPS Growth, Return on Equity, Free Cash Flow.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
BEAM profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
BEAM carries more volatility with a beta of 2.20 — expect wider price swings.
BEAM is growing revenue faster at 324.9% — sustainability is the question.
BEAM generates stronger free cash flow (-131M), providing more financial flexibility.
Bottom Line
BEAM scores higher overall (35/100 vs 24/100) and 324.9% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Beam Therapeutics Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. The company is headquartered in Cambridge, Massachusetts.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?